Literature DB >> 10831685

Transjugular versus percutaneous renal biopsy for the diagnosis of parenchymal disease: comparison of sampling effectiveness and complications.

P Cluzel1, F Martinez, M F Bellin, Y Michalik, H Beaufils, C Jouanneau, O Lucidarme, G Deray, P A Grenier.   

Abstract

PURPOSE: To compare the effectiveness and safety of transjugular renal biopsy with those of percutaneous renal biopsy for diagnosis of renal parenchymal disease.
MATERIALS AND METHODS: Results and complications of 400 consecutive transjugular renal biopsies performed between 1993 and 1998 with a modified Colapinto transjugular hepatic biopsy system were compared retrospectively with those of 400 percutaneous renal biopsies performed during the same period. Transjugular renal biopsy was associated with 14 cardiac and 35 hepatic biopsies. Number of glomeruli per tissue core, adequacy of tissue core for histopathologic diagnosis, and rate and severity of complications were analyzed.
RESULTS: Renal tissue was obtained with percutaneous renal biopsy in 382 (95.5%) of 400 patients and with transjugular renal biopsy in 383 (95.8%) of 400 patients. The mean numbers of intact glomeruli per tissue core with optical microscopy were 11.2 +/- 7.7 (SD) and 9.8 +/- 7.6 for percutaneous renal biopsy and transjugular renal biopsy, respectively. With immunofluorescent microscopy, the mean numbers were 6.4 +/- 5.3 and 4.6 +/- 4.6 for percutaneous renal biopsy and transjugular renal biopsy, respectively. Tissue cores were adequate for histopathologic diagnosis in 98.2% with both techniques. Major complications occurred with transjugular renal biopsy in four patients and with percutaneous renal biopsy in three patients.
CONCLUSION: Use of transjugular renal biopsy provides diagnostic yield and safety similar to those of percutaneous renal biopsy and allows multiorgan biopsy during the same procedure. It can be recommended in patients with percutaneous renal biopsy contraindication or failure.

Entities:  

Mesh:

Year:  2000        PMID: 10831685     DOI: 10.1148/radiology.215.3.r00ma07689

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  14 in total

Review 1.  The Native Kidney Biopsy: Update and Evidence for Best Practice.

Authors:  Jonathan J Hogan; Michaela Mocanu; Jeffrey S Berns
Journal:  Clin J Am Soc Nephrol       Date:  2015-09-02       Impact factor: 8.237

Review 2.  Complications of transjugular biopsies.

Authors:  Rakesh Navuluri; Osman Ahmed
Journal:  Semin Intervent Radiol       Date:  2015-03       Impact factor: 1.513

Review 3.  Alternative renal biopsies: past and present.

Authors:  Li Zhuo; Haifeng Wang; Dapeng Chen; Haitao Lu; Guming Zou; Wenge Li
Journal:  Int Urol Nephrol       Date:  2017-07-29       Impact factor: 2.370

Review 4.  Image-guided adrenal and renal biopsy.

Authors:  Karun V Sharma; Aradhana M Venkatesan; Daniel Swerdlow; Daniel DaSilva; Avi Beck; Nidhi Jain; Bradford J Wood
Journal:  Tech Vasc Interv Radiol       Date:  2010-06

Review 5.  Renal dysfunction in patients with cirrhosis: Where do we stand?

Authors:  Chrysoula Pipili; Evangelos Cholongitas
Journal:  World J Gastrointest Pharmacol Ther       Date:  2014-08-06

Review 6.  Renal biopsy practice: What is the gold standard?

Authors:  Soumeya Brachemi; Guillaume Bollée
Journal:  World J Nephrol       Date:  2014-11-06

7.  Performance of Biopsy Needle With Therapeutic Injection System to Prevent Bleeding Complications.

Authors:  Philip Wong; Kent J Johnson; Roscoe L Warner; Scott I Merz; Grant H Kruger; William F Weitzel
Journal:  J Med Device       Date:  2013-02-04       Impact factor: 0.582

Review 8.  Image-guided urological interventions: What the urologists must know.

Authors:  Chandan J Das; Vinit Baliyan; Sanjay Sharma
Journal:  Indian J Urol       Date:  2015 Jul-Sep

Review 9.  Factors that can minimize bleeding complications after renal biopsy.

Authors:  M S Zhu; J Z Chen; A P Xu
Journal:  Int Urol Nephrol       Date:  2014-08-24       Impact factor: 2.370

10.  Transjugular renal biopsy in high-risk patients: an American case series.

Authors:  Kevin C Abbott; Franco M Musio; Ellen M Chung; Nick N Lomis; John D Lane; Christina M Yuan
Journal:  BMC Nephrol       Date:  2002-07-11       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.